Novo Nordisk says it's now cutting its annual outlook - seeing sales growth, at constant exchange rates, between 13% and 21%, vs. its previous forecast of 16% to 24%, and operating profit growth ...

Danish ships involved in transatlantic slave trade uncovered off Costa Rica - Fridericus Quartus and Christianus Quintus sank ...

Orsted will abandon a major offshore wind farm project in Britain, it said on Wednesday, citing a deteriorating global ...

European stock markets are poised for a mixed and cautious opening on Wednesday as investors globally turn their full ...

Obesity drugmaker Novo Nordisk has today downgraded its 2025 sales forecast, ending a four-year stretch of steady guidance ...

Novo Nordisk now expects sales to grow 13% to 21% in constant currencies this year, from 16% to 24% previously. Operating profit should grow 16% to 24% compared with a previous target of 19% to 27%.

Obesity drugmaker Novo Nordisk downgraded its 2025 sales forecast on Wednesday, ending a four-year stretch of steady guidance ...

Shipping investment manager European Maritime Finance (EMF) has misled investors about the returns and potential risks of its ...

Novo Nordisk (NYSE:NVO) trimmed its full-year 2025 sales and profit forecast on Wednesday, citing weaker-than-expected U.S.

The Danish-flagged commercial fleet could suffer losses of nearly $1bn in the first year of a war involving the world’s major ...

Orsted won’t continue the Hornsea 4 offshore wind project in the U.K. due to rising costs.

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.